logo
  • About
    • AWI Leadership Board
  • Resources by Tumor Type
  • Provider Resources
    • Care Step Pathways
    • Continuing Education
    • Provider Toolkits
    • JADPRO AIM with Immunotherapy Supplement
    • JCO OP AIM with Immunotherapy Supplement
    • Facebook Provider Community
    • News
  • Patient Resources
    • Patient Action Plans
    • Options for Stage III Melanoma
  • International Resources
    • Australia
    • Canada
    • France
    • Germany
    • Italy
    • Portugal
    • Spain
    • UK
  • Videos
    • HCP Videos
    • Patient Videos
  • Contact
  • About
    • AWI Leadership Board
  • Resources by Tumor Type
  • Provider Resources
    • Care Step Pathways
    • Continuing Education
    • Provider Toolkits
    • JADPRO AIM with Immunotherapy Supplement
    • JCO OP AIM with Immunotherapy Supplement
    • Facebook Provider Community
    • News
  • Patient Resources
    • Patient Action Plans
    • Options for Stage III Melanoma
  • International Resources
    • Australia
    • Canada
    • France
    • Germany
    • Italy
    • Portugal
    • Spain
    • UK
  • Videos
    • HCP Videos
    • Patient Videos
  • Contact

The AIM with Immunotherapy Initiative – Home › Forums › Targeted therapy

  • This category has 7 topics, 11 replies, and was last updated March 1, 2018 at 12:20 am by Lisa Kottschade.
    • Forum
    • Topics
    • Posts
    • Last Post
    • Expectations for therapy
    • 1
    • 2
    • Reply To: Targeted therapies for adjuvant therapy

      November 3, 2017 at 2:07 am

      Virginia Seery

    • Dosing and administration
    • 2
    • 4
    • New BRAF/MEK inhibitors coming to market

      March 1, 2018 at 12:20 am

      Lisa Kottschade

    • Side-effect management
    • 2
    • 5
    • Reply To: ? odd toxicity

      January 27, 2018 at 11:50 pm

      Krista Rubin

    • Reimbursement
    • 0
    • 0
    • December 19, 2017 at 7:44 pm

      LisaTushla

    • Other
    • 2
    • 7
    • Reply To: Adjuvant Treatment with Targeted Therapy

      February 23, 2018 at 5:43 pm

      Mollie Reed

  •  

Login

Log In
Register Lost Password

Latest Activity

  • New BRAF/MEK inhibitors coming to market
    topic by Lisa Kottschade
    March 1
    in Dosing and administration
  • Adjuvant Immunotherapy in stage IIIA patients
    topic by Lisa Kottschade
    March 1
    in Expectations for therapy
  • Influenza and Tamiflu and Immunotherapy
    reply by Kathleen Madden
    February 25
    in Other
  • ASCO/NCCN guidlines now out
    reply by Mollie Reed
    February 23
    in Side-effect management
  • hepatotoxicity
    reply by Mollie Reed
    February 23
    in Side-effect management
© 2021 AIM with Immunotherapy. All rights reserved.
  • Terms
  • Privacy